Israeli company Zebra Medical Vision has obtained the European CE-Mark for the use of its new artificial intelligence (AI) algorithm to detect various types of intracranial haemorrhages or brain bleeds.

The regulatory approval expands the firm’s Deep Learning Imaging Analytics platform under its All-In-One (AI1) business model.

This imaging platform also includes algorithms to automatically identify low bone mineral density, vertebral fractures, fatty liver, coronary artery calcium and emphysema, among other conditions.

According to statistics, around six million deaths per year occur due to brain bleed related conditions and therefore timely detection is considered important. The new algorithm is intended to address these challenges by accurately detecting such bleeds.

“According to statistics, around six million deaths per year occur due to brain bleed related conditions and therefore timely detection is considered important.”

Zebra Medical Vision co-founder and CEO Elad Benjamin said: “We’re excited to announce our first acute care algorithm with the potential to help radiologists better manage their workload, and properly prioritise urgent cases over others.

“This helps take PACS & Worklist management systems to the next level in helping radiologists manage patient care, all in a transparent and globally affordable business model.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

With plans to introduce the new algorithm for point-of-care, the firm expects to equip physicians with better precision and minimal delay.

Furthermore, Zebra Medical is planning to launch additional high impact algorithms to deliver AI-based automated radiology assistance.

Intermountain Healthcare clinical and outreach services chief Dr Mike Phillips said: “The ability to alert radiologists and surgeons to the presence of brain bleeds is critical, and will bring significant benefits in patient care to healthcare organisations.”

In March last year, Intermountain Healthcare selected Zebra Medical Vision to deploy enterprise imaging analytics.